Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Do

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Pathology|December 1, 2006
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretionC T Ong, Y T Khoo, E K Tan, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Eye (London, England)|August 9, 2014
Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivityE Hatef, M Hanout, A Moradi, et al.
Eye (London, England)|December 3, 2011
Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edemaM A Ibrahim, Y J Sepah, R C A Symons, et al.
Eye (London, England)|August 1, 2015
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)D V Do, Y J Sepah, D Boyer, et al.
Eye (London, England)|August 23, 2014
Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumabA Moradi, Y J Sepah, M A Ibrahim, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
Transboundary and Emerging Diseases|August 18, 2017
Trade patterns facilitating highly pathogenic avian influenza virus dissemination in the free-grazing layer duck system in VietnamA Meyer, T X Dinh, T A Han, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Hepatoma-derived growth factor and its role in keloid pathogenesisB N S Ooi, A Mukhopadhyay, J Masilamani, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Pathology|December 1, 2006
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretionC T Ong, Y T Khoo, E K Tan, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Eye (London, England)|August 9, 2014
Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivityE Hatef, M Hanout, A Moradi, et al.
Eye (London, England)|December 3, 2011
Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edemaM A Ibrahim, Y J Sepah, R C A Symons, et al.
Eye (London, England)|August 1, 2015
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)D V Do, Y J Sepah, D Boyer, et al.
Eye (London, England)|August 23, 2014
Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumabA Moradi, Y J Sepah, M A Ibrahim, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
Transboundary and Emerging Diseases|August 18, 2017
Trade patterns facilitating highly pathogenic avian influenza virus dissemination in the free-grazing layer duck system in VietnamA Meyer, T X Dinh, T A Han, et al.
Journal of Cellular and Molecular Medicine|May 13, 2009
Hepatoma-derived growth factor and its role in keloid pathogenesisB N S Ooi, A Mukhopadhyay, J Masilamani, et al.
The British Journal of Dermatology|September 18, 2010
The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?A Mukhopadhyay, D V Do, C T Ong, et al.
Pageof 3